CALR and neoplasm: Increased calreticulin expression has been observed in various tumor-cell lines following in vitro and in vivo treatment with sublethal EBRT and proton radiation, and is believed to play a critical role in enhancing antigen-specific CTL recognition of tumor cells [22, 25].